BLOG

Sunday, April 4, 2021

Zydus Cadila seeks approval for its repurpose Hepatitis C drug for Covid-19

Cadila's Hepatitis C drug has shown promising interim results as a treatment for Covid-19 in a late-stage trial, the drugmaker said on Monday

from Home Page https://ift.tt/3ums9DX
via IFTTT
at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Omicron has cast a shadow of uncertainty on growth outlook: IndiGo CEO

However, the airline is stronger now when compared to situation in 2020 during the first wave of the pandemic, says Ronojoy Dutta from Com...